ALLEAN JOHNSON: Open Payments
NPI 1144540063 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 23 payments from 11 companies in 2025. Trend: 2023 $56 · 2024 $170 · 2025 $742
Education: $394Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $281 |
| Aveo Pharmaceuticals, Inc. | 5 | $152 |
| Janssen Biotech, Inc. | 2 | $102 |
| E.R. Squibb & Sons, L.L.C. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: LYNPARZA, FOTIVDA, DARZALEX, OPDIVO, ENHERTU, KISQALI, Trodelvy, Venclexta.
Industry payments across OR — which companies pay providers there.
